Stuart David Greenhill

Stuart David Greenhill

Auto-generated profile, based on publicly available information

Stuart David Greenhill

Aston Institute of Health and Neurodevelopment, College of Health and Life Sciences, Aston University, Aston Triangle, B4 7ET, Birmingham, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2008 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AHAnthony J. Harmar
Anthony J. Harmar
RHRebecca A. Hills
Rebecca A. Hills
EREdward M. Rosser
Edward M. Rosser
MJMartin Jones
Martin Jones
OBO. Peter Buneman
O. Peter Buneman
Michael SpeddingMichael Spedding
Michael Spedding
The IUPHAR database (IUPHAR-DB) integrates peer-reviewed pharmacological, chemical, genetic, functional and anatomical information on the 354 nonsensory G protein-coupled receptors (GPCRs), 71 ligand-gated ion channel subunits and 141 voltage-gated-like ion channel subunits encoded by the human, rat and mouse genomes. These genes represent the targets of approximately one-third of currently approved drugs and are a major focus of drug discovery and development programs in the pharmaceutical industry. IUPHAR-DB provides a comprehensive description of the genes and their functions, with information on protein structure and interactions, ligands, expression patterns, signaling mechanisms, functional assays and biologically important receptor variants (e.g. single nucleotide polymorphisms and splice variants). In addition, the phenotypes resulting from altered gene expression (e.g. in genetically altered animals or in human genetic disorders) are described. The content of the database is peer reviewed by members of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR); the data are provided through manual curation of the primary literature by a network of over 60 subcommittees of NC-IUPHAR. Links to other bioinformatics resources, such as NCBI, Uniprot, HGNC and the rat and mouse genome databases are provided. IUPHAR-DB is freely available at http://www.iuphar-db.org.

20 December 2016 in eLife
Verified
Journal Article
Open access
Miou ZhouMiou Zhou
Miou Zhou
SGStuart Greenhill
Stuart Greenhill
SHShan Huang
Shan Huang
TSTawnie K Silva
Tawnie K Silva
YSYoshitake Sano
Yoshitake Sano
ASAlcino J Silva
Alcino J Silva
Although the role of CCR5 in immunity and in HIV infection has been studied widely, its role in neuronal plasticity, learning and memory is not understood. Here, we report that decreasing the function of CCR5 increases MAPK/CREB signaling, long-term potentiation (LTP), and hippocampus-dependent memory in mice, while neuronal CCR5 overexpression caused memory deficits. Decreasing CCR5 function in mouse barrel cortex also resulted in enhanced spike timing dependent plasticity and consequently, dramatically accelerated experience-dependent plasticity. These results suggest that CCR5 is a powerful suppressor for plasticity and memory, and CCR5 over-activation by viral proteins may contribute to HIV-associated cognitive deficits. Consistent with this hypothesis, the HIV V3 peptide caused LTP, signaling and memory deficits that were prevented by Ccr5 knockout or knockdown. Overall, our results demonstrate that CCR5 plays an important role in neuroplasticity, learning and memory, and indicate that CCR5 has a role in the cognitive deficits caused by HIV.

13 February 2023 in Neuron
Verified
Journal Article
Open access
EREvan C. Rosenberg
Evan C. Rosenberg
SCSimon Chamberland
Simon Chamberland
MBMichael Bazelot
Michael Bazelot
ENErica R. Nebet
Erica R. Nebet
XWXiaohan Wang
Xiaohan Wang
RTRichard W. Tsien
Richard W. Tsien
Cannabidiol (CBD), a non-euphoric component of cannabis, reduces seizures in multiple forms of pediatric epilepsies, but the mechanism(s) of anti-seizure action remain unclear. In one leading model, CBD acts at glutamatergic axon terminals, blocking the pro-excitatory actions of an endogenous membrane phospholipid, lysophosphatidylinositol (LPI), at the G-protein-coupled receptor GPR55. However, the impact of LPI-GPR55 signaling at inhibitory synapses and in epileptogenesis remains underexplored. We found that LPI transiently increased hippocampal CA3-CA1 excitatory presynaptic release probability and evoked synaptic strength in WT mice, while attenuating inhibitory postsynaptic strength by decreasing GABAARγ2 and gephyrin puncta. LPI effects at excitatory and inhibitory synapses were eliminated by CBD pre-treatment and absent after GPR55 deletion. Acute pentylenetrazole-induced seizures elevated GPR55 and LPI levels, and chronic lithium-pilocarpine-induced epileptogenesis potentiated LPI's pro-excitatory effects. We propose that CBD exerts potential anti-seizure effects by blocking LPI's synaptic effects and dampening hyperexcitability.

1 November 2015 in Neuron
Verified
Journal Article
Open access
SGStuart David Greenhill
Stuart David Greenhill
ARAdam Ranson
Adam Ranson
KFKevin Fox
Kevin Fox
Layer 5 contains the major projection neurons of the neocortex and is composed of two major cell types: regular spiking (RS) cells, which have cortico-cortical projections, and intrinsic bursting cells (IB), which have subcortical projections. Little is known about the plasticity processes and specifically the molecular mechanisms by which these two cell classes develop and maintain their unique integrative properties. In this study, we find that RS and IB cells show fundementally different experience-dependent plasticity processes and integrate Hebbian and homeostatic components of plasticity differently. Both RS and IB cells showed TNFα-dependent homeostatic plasticity in response to sensory deprivation, but IB cells were capable of a much faster synaptic depression and homeostatic rebound than RS cells. Only IB cells showed input-specific potentiation that depended on CaMKII autophosphorylation. Our findings demonstrate that plasticity mechanisms are not uniform within the neocortex, even within a cortical layer, but are specialized within subcircuits.

24 July 2015 in Science
Verified
Journal Article
Closed access
PDF file
SGStuart D. Greenhill
Stuart D. Greenhill
KJKonrad Juczewski
Konrad Juczewski
AHAnnelies M. de Haan
Annelies M. de Haan
GSGillian Seaton
Gillian Seaton
KFKevin Fox
Kevin Fox
NHNeil R. Hardingham
Neil R. Hardingham
Keeping synaptic plasticity plastic: Neuronal synapses in the brain adjust according to shifting demands as we experience the world. This synaptic plasticity forms the basis for critical periods in the visual and somatosensory systems. Greenhill et al. have now found, in mice, a critical period for the development of plasticity itself. At the core is a protein that in its mutant form is associated with schizophrenia. Disrupting this protein's function temporarily during early development caused a failure in brain plasticity in adult mice. Science , this issue p. 424

20 September 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
SWSukhvir K. Wright
Sukhvir K. Wright
RRRichard E. Rosch
Richard E. Rosch
MWMax A. Wilson
Max A. Wilson
MUManoj A. Upadhya
Manoj A. Upadhya
DDDivya R. Dhangar
Divya R. Dhangar
GWGavin L. Woodhall
Gavin L. Woodhall
Seizures are a prominent feature in N-Methyl-D-Aspartate receptor antibody (NMDAR antibody) encephalitis, a distinct neuro-immunological disorder in which specific human autoantibodies bind and crosslink the surface of NMDAR proteins thereby causing internalization and a state of NMDAR hypofunction. To further understand ictogenesis in this disorder, and to test a potential treatment compound, we developed an NMDAR antibody mediated rat seizure model that displays spontaneous epileptiform activity in vivo and in vitro. Using a combination of electrophysiological and dynamic causal modelling techniques we show that, contrary to expectation, reduction of synaptic excitatory, but not inhibitory, neurotransmission underlies the ictal events through alterations in the dynamical behaviour of microcircuits in brain tissue. Moreover, in vitro application of a neurosteroid, pregnenolone sulphate, that upregulates NMDARs, reduced established ictal activity. This proof-of-concept study highlights the complexity of circuit disturbances that may lead to seizures and the potential use of receptor-specific treatments in antibody-mediated seizures and epilepsy.